25 citations · 45 across the 2 of their papers we have counts for
2 papers
stat.AP2020★ 20 cited
Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing events
Regina Stegherr, Claudia Schmoor, Michael Lübbert +2
Safety analyses in terms of adverse events (AEs) are an important aspect of benefit-risk assessments of therapies. Compared to efficacy analyses AE analyses are often rather simpli…
q-bio.GN2019★ 25 cited
Netboost: Boosting-supported network analysis improves high-dimensional omics prediction in acute myeloid leukemia and Huntington's disease
Pascal Schlosser, Jochen Knaus, Maximilian Schmutz +7
Background: State-of-the art selection methods fail to identify weak but cumulative effects of features found in many high-dimensional omics datasets. Nevertheless, these features…